ARYA Sciences Acquisition Corp IV logo

ARYA Sciences Acquisition Corp IV (ARYD)

Market Open
3 Jul, 20:00
NASDAQ (CM) NASDAQ (CM)
$
1. 55
+0.02
+1.31%
$
50.04M Market Cap
- P/E Ratio
0% Div Yield
49,958 Volume
- Eps
$ 1.53
Previous Close
Day Range
1.45 1.64
Year Range
0.62 11.57
Want to track ARYD and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

ARYD trading today higher at $1.55, an increase of 1.31% from yesterday's close, completing a monthly increase of 22.05% or $0.28. Over the past 12 months, ARYD stock gained 27.05%.
ARYD is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on NASDAQ (CM) (USD).

ARYD Chart

Chart

Empty chart
The chart has 2 Y axes displaying values, and values.
Loading, please wait...
End of interactive chart.

ARYA Sciences Acquisition Corp IV Dividends

ARYD is not paying dividends to its shareholders.

ARYA Sciences Acquisition Corp IV Earnings

ARYD have yet to publish their earning reports.
ARYD is not paying dividends to its shareholders.
ARYD have yet to publish their earning reports.

ARYA Sciences Acquisition Corp IV (ARYD) FAQ

What is the stock price today?

The current price is $1.55.

On which exchange is it traded?

ARYA Sciences Acquisition Corp IV is listed on NASDAQ (CM).

What is its stock symbol?

The ticker symbol is ARYD.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0%.

What is its market cap?

As of today, the market cap is 50.04M.

Has ARYA Sciences Acquisition Corp IV ever had a stock split?

No, there has never been a stock split.

ARYA Sciences Acquisition Corp IV Profile

Shell Companies Industry
Financial Services Sector
Adam Leo Stone CEO
NASDAQ (CM) Exchange
G31659108 Cusip
US Country
3 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Arya Sciences Acquisition Corp IV is a corporation that has positioned itself uniquely within the business world due to its lean operation approach, as it reports having no significant operations of its own. Incorporated in 2020 and based in New York, New York, the company's primary objective is to facilitate substantial business transformations through a variety of means such as mergers, share exchanges, asset acquisitions, share purchases, reorganizations, or similar business combinations. Focusing mainly on targets within the North American or European markets, Arya Sciences Acquisition Corp IV has a particular interest in companies operating in the life sciences and medical technology sectors. This strategic intent aims to capitalize on the evolving opportunities within these industries, leveraging its capabilities to drive growth and innovation through successful partnerships and acquisitions.

Products and Services

Arya Sciences Acquisition Corp IV does not offer traditional products or services due to its singular aim of acquiring and merging with other businesses in specific sectors. However, its offerings can be understood in terms of the strategic opportunities it provides:

  • Merger and Acquisition Facilitation: Offering expertise in merging with, acquiring, or facilitating the reorganization of companies within the life sciences and medical tech sectors, providing these enterprises with the strategic alignments necessary for growth and development.
  • Business Combination Opportunities: Facilitating share exchanges, asset acquisitions, or similar deals, Arya Sciences Acquisition Corp IV enables companies within its target sectors to accelerate their growth trajectories and achieve synergies that can lead to enhanced innovation and market expansion.

Contact Information

Address: 51 Astor Place
Phone: 212 284 2300